Table 1.
Baseline characteristics.
Total | Waiting | Tango | p-Value | |
---|---|---|---|---|
Number of patients, n (%) | 60 (100) | 30 (100) | 30 (100) | |
Age, years, mean (SD) | 60.5 (10.3) | 59.3 (11.0) | 61.7 (9.4) | 0.377 |
Body mass index (BMI) | ||||
Normal (18.5 ≤ BMI < 25) | 39 (65) | 21 (70) | 18 (60) | |
Overweight (25 ≤ BMI < 30) | 13 (22) | 6 (20) | 7 (23) | 0.668 |
Obese (BMI ≥ 30) | 8 (13) | 3 (10) | 5 (17) | |
Currently employed, n (%) | 23 (38) | 12 (40) | 11 (37) | 1 |
Living in partnership, n (%) | 39 (65) | 19 (63) | 20 (67) | 1 |
Years since first diagnosis: mean (SD) | 1.7 (0.7) | 1.7 (0.7) | 1.6 (0.6) | 0.614 |
UICC stages, n (%) | ||||
I | 28 (47) | 12 (40) | 16 (53) | |
II | 23 (38) | 14 (47) | 9 (30) | 0.413 |
III | 9 (15) | 4 (13) | 5 (17) | |
Hormonal status, n (%) | ||||
Premenopausal | 3 (5) | 3 (10) | 0 | |
Postmenopausal | 57 (95) | 27 (90) | 30 (100) | 0.236 |
Triple-negative status, n (%) | 6 (10) | 2 (7) | 4 (13) | 0.667 |
Oncological Interventions, n (%) | ||||
Surgery | 60 (100) | 30 (100) | 30 (100) | 1 |
Radiation | 52 (87) | 25 (83) | 27 (90) | 0.704 |
Endocrine therapy | 39 (65) | 21 (70) | 18 (60) | 0.588 |
Chemotherapy | 31 (52) | 16 (53) | 15 (50) | 1 |
Immunotherapy | 6 (10) | 3 (10) | 3 (10) | 1 |
Sportive activities, n (%) | ||||
No | 9 (15) | 5 (17) | 4 (13) | |
Occasionally | 13 (22) | 4 (13) | 9 (30) | 0.293 |
Regularly | 38 (64) | 21 (70) | 17 (57) | |
Dance experience, n (%) | ||||
No | 19 (32) | 12 (40) | 7 (23) | |
Yes, in the past | 38 (63) | 16 (53) | 22 (73) | 0.273 |
Yes, current | 3 (5) | 2 (7) | 1 (3) | |
CFS-D | ||||
Total fatigue score, mean (SD) | 32.2 (9.0) | 33.7 (7.6) | 30.6 (10.0) | 0.195 |
Physical fatigue, mean (SD) | 14.1 (4.1) | 14.9 (3.8) | 13.3 (4.2) | 0.109 |
Affective fatigue, mean (SD) | 6.9 (2.6) | 7.3 (2.2) | 6.4 (2.8) | 0.196 |
Cognitive fatigue, mean (SD) | 11.2 (3.5) | 11.4 (3.0) | 10.9 (4.0) | 0.605 |
CFS-D: Cancer fatigue scale, German version; n: numbers; SD: standard deviation.